Latest Opioid antagonists Stories
Where you live makes a difference ATLANTA, April 24, 2015 /PRNewswire-USNewswire/ -- Allowing more basic emergency medical service (EMS) staff to administer naloxone could reduce drug
LAVAL, Quebec and TARRYTOWN, N.Y., April 24, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc.
NEW YORK, April 22, 2015 /PRNewswire/ -- Lightlake Therapeutics Inc.
Expansion of project made possible by Staunton Farm Foundation grant PITTSBURGH, April 20, 2015 /PRNewswire-USNewswire/ --
PSP Working with Departments of Health and Drug & Alcohol Programs to Make Naloxone Available to First Responders HARRISBURG, Pa., April 7, 2015 /PRNewswire-USNewswire/ -- The Wolf
Cash Payment Resulting from First Commercial Sale of MOVANTIK(TM) (naloxegol) Tablets in the US SAN FRANCISCO, April 2, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced
FLORHAM PARK, N.J., March 30, 2015 /PRNewswire/ -- Naldemedine, an investigational peripherally acting mu-opioid receptor antagonist (PAMORA) under development by Shionogi & Co., Ltd., met
In a recent bill approved by West Virginia, Naloxone will be available to everyone in need of treating a victim of an opiate overdose, according to a recent article by Metro News.
The Harford County Health Department and The Bergand Group have partnered to host an evening for friends, family, and professionals involved in the treatment and prevention of addiction and drug
Lightlake invites individual and institutional investors to attend interactive real-time presentation on Lightlake's progress with its opioid overdose reversal treatment and achievements in other areas. NEW
- An armed gangster.